National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorANRS, Emerging Infectious Diseases
About this trial
This is a multicentre observational study with prospective and retrospective data collection and retrospective data collection and biological collection from patients with HBV/HDV co-infection.
Eligibility criteria
Qualifiers
Age > 18 years,
Presenting a chronic HDV infection (positive serology),
Who gave his written informed consent before any intervention and the day of inclusion at the latest,
Affiliated to Health Insurance or to the "Aide Médicale d'Etat" (request for exemption pending).
Disqualifiers
Patient participating in another biomedical research with an exclusion period ongoing at inclusion,
Vulnerable patient (minor, adults legally protected: under judicial protection, guardianship, or supervision, persons deprived of their liberty).
Patients with predictable difficulties of follow-up according to the investigator.
Trial design
Treatments tested in this trial
- Blood draw for the laboratory assessment
Treatment groups
800 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov